NCT07038343 2026-05-13AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)Avenzo Therapeutics, Inc.Phase 1/2 Recruiting480 enrolled